All Posts By: lisaweiner

Brain cholesterol map could lead to neurodegeneration therapies, help guide surgery

William Griffiths and Swansea University colleagues have developed a method to map cholesterol in the brain, and understand potential molecule conversion. This is the first technology that can map cholesterol metabolism in defined locations at microscopic levels, and visualize how it changes in pathological niches in the brain. While only studied on mice, the hope […]

AirPod light sensors for health monitoring

A source has told DigiTimes that Apple supplier ASE Technology will manufacture ambient light sensors for AirPods. This could be used to monitor step count, head movement, and heart rate. It could also track blood oxygen levels — a key metric in detecting COVID-19. The shift from consumer-grade to less-obtrusive medical-grade health monitoring at scale […]

Tattoo electrodes for long-term EEG, MEG measurements

Graz University professor Francesco Greco has built on his earlier work to create advanced inkjet printed conductive polymer electrodes on tattoo paper. The composition and thickness of the transfer paper and conductive polymer have been optimized to achieve a better electrode/skin connection and improve EEG signal quality. The cheap, user-friendly, dry electrodes have shown similar […]

Sniff test predicts consciousness recovery

Cambridge scientist Anat Arzi and Yaron Sacher of Israel’s Beit Lowenstein Rehabilitation Center have developed a simple olfactory consciousness test. In a study, 43 unconscious brain-injured pateients were presented with jars containing various smells under their noses. Scents included pleasant shampoo, unpleasant rotten fish, and no odor. Scientists measured the volume of air inhaled through […]

Stem cell treatment for ARDS in COVID-19 patients

Last week, Pluristem released initial results from its compassionate use program for the treatment of patients with acute respiratory failure and inflammatory complications resulting from COVID-19. The treatment was administered in an Israeli hospital. All seven ICU patients with ARDS treated with Pluristem’s PLX cell therapy have survived. 6 out of 7 have completed the […]

Directional DBS system targets GPi to relieve Parkinson’s symptoms

Abbott received FDA approval for an expanded indication for its Deep Brain Stimulation system, to include targeting of internal globus pallidus. The GPi plays an integral role in motor function. When targeted with DBS, Parkonson’s symptoms not adequately controlled by medication can improve. The directed stimulation system is now approved for all major targets used […]